CD19 CAR-T cells (autologous)

CD19-specific chimeric antigen receptor T cells · St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 CAR-T cells (autologous), covering 2024-10-30 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

See pricing